• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 miR-222 与退行性心脏瓣膜病患者的心房颤动独立相关。

Serum miR-222 is independently associated with atrial fibrillation in patients with degenerative valvular heart disease.

机构信息

Department of Gereology, Affiliated Huai'an Hospital of Xuzhou Medical University, ', Huaian, Jiangsu Province, 223002, China.

Department of Clinical Laboratory, Affiliated Huai'an Hospital of Xuzhou Medical University, ', Huaian, Jiangsu Province, 223002, China.

出版信息

BMC Cardiovasc Disord. 2021 Feb 16;21(1):98. doi: 10.1186/s12872-021-01909-7.

DOI:10.1186/s12872-021-01909-7
PMID:33593281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7885218/
Abstract

BACKGROUND

Inflammation is involved in the progression of degenerative valvular heart disease (DVHD). microRNA-222 (miR-222) contributes to inflammation-mediated vascular remodeling, but its involvement in DVHD in relation to atrial fibrillation (AF) is unknown. This study aimed to investigate the changes in miR-222, interleukin (IL)-6, high-sensitivity C-reactive protein (hs-CRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with DVHD complicated with AF.

METHODS

This was a case control study of patients with DVHD who were hospitalized at the Geriatrics Department of the Affiliated Huai'an Hospital of Xuzhou Medical University between 01/2017 and 08/2018. The participants were grouped according to the presence of AF, and serum miR-222, IL-6, hs-CRP, and NT-proBNP levels were compared.

RESULTS

There were fifty-two participants (28 males) in the DVHD with AF group, aged 60-80 years (73.0 ± 5.9 years). Sixty participants (31 males) were included in the DVHD without AF group, aged 60-80 years (71.9 ± 6.92 years). There were no significant differences in age, sex, body mass index, fasting blood glucose, triglycerides, cholesterol, and blood pressure between the two groups. The serum levels of miRNA-222, IL-6, hs-CRP, and NT-proBNP in DVHD patients were significantly higher in those with AF compared with the non-AF group (all P < 0.05). Correlation analyses revealed that IL-6, hs-CRP, and NT-proBNP levels were positively correlated with miR-222 levels in all patients (IL-6: r = 0.507, P < 0.01; hs-CRP: r = 0.390, P < 0.01; NT-proBNP: r = 0.509, P < 0.01).

CONCLUSIONS

Serum miR-222 was independently associated with AF in patients with DVHD.

摘要

背景

炎症参与退行性心脏瓣膜病(DVHD)的进展。microRNA-222(miR-222)有助于炎症介导的血管重塑,但它与房颤(AF)相关的 DVHD 之间的关系尚不清楚。本研究旨在探讨 miR-222、白细胞介素(IL)-6、高敏 C 反应蛋白(hs-CRP)和 N 末端脑利钠肽前体(NT-proBNP)在患有 DVHD 合并 AF 的患者中的变化。

方法

这是一项病例对照研究,纳入了 2017 年 1 月至 2018 年 8 月期间在徐州医科大学附属医院老年科住院的 DVHD 患者。根据是否存在 AF 对患者进行分组,并比较血清 miR-222、IL-6、hs-CRP 和 NT-proBNP 水平。

结果

AF 组有 52 名患者(28 名男性),年龄 60-80 岁(73.0±5.9 岁)。无 AF 组有 60 名患者(31 名男性),年龄 60-80 岁(71.9±6.92 岁)。两组在年龄、性别、体重指数、空腹血糖、甘油三酯、胆固醇和血压方面无差异。与非 AF 组相比,DVHD 患者的血清 miR-222、IL-6、hs-CRP 和 NT-proBNP 水平在 AF 组中显著升高(均 P<0.05)。相关性分析显示,在所有患者中,IL-6、hs-CRP 和 NT-proBNP 水平与 miR-222 水平呈正相关(IL-6:r=0.507,P<0.01;hs-CRP:r=0.390,P<0.01;NT-proBNP:r=0.509,P<0.01)。

结论

血清 miR-222 与 DVHD 患者的 AF 独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/7885218/40b75be769bd/12872_2021_1909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/7885218/40b75be769bd/12872_2021_1909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/7885218/40b75be769bd/12872_2021_1909_Fig1_HTML.jpg

相似文献

1
Serum miR-222 is independently associated with atrial fibrillation in patients with degenerative valvular heart disease.血清 miR-222 与退行性心脏瓣膜病患者的心房颤动独立相关。
BMC Cardiovasc Disord. 2021 Feb 16;21(1):98. doi: 10.1186/s12872-021-01909-7.
2
NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.N末端B型利钠肽原(NT-proBNP)而非心房钠尿肽(ANP)和C反应蛋白,可预测接受肺静脉隔离术患者的阵发性心房颤动。
J Interv Card Electrophysiol. 2012 Jan;33(1):93-100. doi: 10.1007/s10840-011-9606-9. Epub 2011 Sep 21.
3
The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.纤溶酶原激活物抑制物-1 在阵发性和持续性心房颤动中的作用。
Cytokine. 2018 Mar;103:63-68. doi: 10.1016/j.cyto.2017.12.026. Epub 2018 Jan 8.
4
Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者血浆N末端脑钠肽水平或左心室充盈压升高与血栓栓塞风险之间的关联。
J Cardiol. 2016 Aug;68(2):110-6. doi: 10.1016/j.jjcc.2015.11.015. Epub 2016 Jan 6.
5
NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.N末端B型利钠肽原是新发房颤的有力预测指标——多标志物方法的验证
Int J Cardiol. 2016 Nov 15;223:74-81. doi: 10.1016/j.ijcard.2016.08.001. Epub 2016 Aug 4.
6
Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.肥胖和 NT-proBNP 与 ARIC 研究中心律失常的发生的联合关联。
J Am Heart Assoc. 2019 Oct;8(19):e013294. doi: 10.1161/JAHA.119.013294. Epub 2019 Sep 28.
7
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.持续性心房颤动中的高敏肌钙蛋白I——与N末端B型利钠肽原以及炎症和止血标志物的关系
Scand J Clin Lab Invest. 2018 Sep;78(5):386-392. doi: 10.1080/00365513.2018.1481224. Epub 2018 Jun 22.
8
Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.NT-proANP 和 NT-proBNP 在心房颤动患者中的作用:与心房颤动进展表型的关系。
Heart Rhythm. 2018 Aug;15(8):1132-1137. doi: 10.1016/j.hrthm.2018.03.021. Epub 2018 Mar 29.
9
Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation.血清 N 末端脑利钠肽前体水平及其在心房颤动患者中的临床意义。
Clin Cardiol. 2009 Dec;32(12):E1-5. doi: 10.1002/clc.20478.
10
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.血清淀粉样蛋白 A 和 C 反应蛋白可独立预测左心室功能正常的心房颤动患者电复律后的复发。
Can J Cardiol. 2012 Sep-Oct;28(5):537-41. doi: 10.1016/j.cjca.2012.02.014. Epub 2012 May 1.

引用本文的文献

1
Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease.退行性主动脉瓣疾病的病理生理机制进展
Cardiol Res. 2025 Apr;16(2):86-101. doi: 10.14740/cr2012. Epub 2025 Feb 18.
2
Plasma microRNAs as Biomarkers for Predicting Radiotherapy Treatment-Induced Cardiotoxicity in Lung Cancer.血浆微小RNA作为预测肺癌放疗所致心脏毒性的生物标志物
Life (Basel). 2024 Dec 6;14(12):1619. doi: 10.3390/life14121619.
3
MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential.心房颤动中的微小RNA:机制、血管影响及治疗潜力

本文引用的文献

1
The Integrative Regulatory Network of circRNA, microRNA, and mRNA in Atrial Fibrillation.心房颤动中环RNA、微小RNA和信使RNA的综合调控网络
Front Genet. 2019 Jun 13;10:526. doi: 10.3389/fgene.2019.00526. eCollection 2019.
2
The Potential for microRNA Therapeutics and Clinical Research.微小RNA疗法的潜力与临床研究
Front Genet. 2019 May 16;10:478. doi: 10.3389/fgene.2019.00478. eCollection 2019.
3
Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.血清循环miR-150是急性心肌梗死后心力衰竭的一个预测指标。
Biomedicines. 2024 Apr 6;12(4):811. doi: 10.3390/biomedicines12040811.
4
The right ventricle in tetralogy of Fallot: adaptation to sequential loading.法洛四联症中的右心室:对顺序负荷的适应
Front Pediatr. 2023 Mar 16;11:1098248. doi: 10.3389/fped.2023.1098248. eCollection 2023.
5
MicroRNAs in Cancer and Cardiovascular Disease.微小 RNA 在癌症和心血管疾病中的作用。
Cells. 2022 Nov 10;11(22):3551. doi: 10.3390/cells11223551.
Int Heart J. 2019 Mar 20;60(2):280-286. doi: 10.1536/ihj.18-306. Epub 2019 Feb 8.
4
MicroRNA-138 Suppresses Osteoblastic Differentiation of Valvular Interstitial Cells in Degenerative Calcific Aortic Valve Disease.微小RNA-138抑制退行性钙化性主动脉瓣疾病中瓣膜间质细胞的成骨分化
Int Heart J. 2019 Jan 25;60(1):136-144. doi: 10.1536/ihj.18-086. Epub 2018 Nov 20.
5
Cadherin-11 as a regulator of valve myofibroblast mechanobiology.钙黏蛋白 11 作为瓣膜成纤维细胞力学生物学调节剂。
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1614-H1626. doi: 10.1152/ajpheart.00277.2018. Epub 2018 Oct 25.
6
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.微小RNA生物合成、作用机制及循环概述
Front Endocrinol (Lausanne). 2018 Aug 3;9:402. doi: 10.3389/fendo.2018.00402. eCollection 2018.
7
Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.钙化性主动脉瓣疾病的病理生理学进展提出了新的分子治疗靶点。
Front Cardiovasc Med. 2018 Mar 14;5:21. doi: 10.3389/fcvm.2018.00021. eCollection 2018.
8
Effects of microRNA-330 on vulnerable atherosclerotic plaques formation and vascular endothelial cell proliferation through the WNT signaling pathway in acute coronary syndrome.微小 RNA-330 通过 WNT 信号通路对急性冠脉综合征易损性动脉粥样硬化斑块形成及血管内皮细胞增殖的影响。
J Cell Biochem. 2018 Jun;119(6):4514-4527. doi: 10.1002/jcb.26584. Epub 2018 Mar 1.
9
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
10
Differential Expression of MicroRNAs in Calcific Aortic Stenosis.钙化性主动脉瓣狭窄中微小RNA的差异表达
Clin Lab. 2017 Jul 1;63(7):1163-1170. doi: 10.7754/Clin.Lab.2017.170108.